A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study.
Matsumoto, Kimihiro
A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study. [electronic resource] - International journal of hematology Jun 2015 - 554-62 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
1865-3774
10.1007/s12185-015-1767-3 doi
Adult
Aged
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
B-Lymphocytes--drug effects
Bendamustine Hydrochloride--adverse effects
Drug Administration Schedule
Female
Humans
Leukopenia--chemically induced
Lymphoma, B-Cell--drug therapy
Lymphoma, Mantle-Cell--drug therapy
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Neutropenia--chemically induced
Rituximab--administration & dosage
Treatment Outcome
Young Adult
A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study. [electronic resource] - International journal of hematology Jun 2015 - 554-62 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
1865-3774
10.1007/s12185-015-1767-3 doi
Adult
Aged
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
B-Lymphocytes--drug effects
Bendamustine Hydrochloride--adverse effects
Drug Administration Schedule
Female
Humans
Leukopenia--chemically induced
Lymphoma, B-Cell--drug therapy
Lymphoma, Mantle-Cell--drug therapy
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Neutropenia--chemically induced
Rituximab--administration & dosage
Treatment Outcome
Young Adult